What are the adverse reactions of Apelvis?

Alpelisib, sold under the brand name Piqray and others, is a drug used to treat certain types of breast cancer in both men and women that have progressed or metastasized to nearby areas of the body and also have a PIK3CA mutation. Apelvis is used with fulvestrant. It is taken by mouth and is marketed by Novartis. In order to minimize side effects and maximize the therapeutic effect of Apelvis, patients need to strictly follow the instructions of a specialist.

Patients may experience some significant side effects while taking Apelvis. Patients should notify their healthcare provider immediately if they develop signs of an allergic reaction, such as difficulty breathing, hives, itchy rash, irritability, facial/throat swelling, rapid heartbeat; or severe skin reaction, such as burning eyes, skin pain, fever, skin abrasions, blistering, or peeling.

In addition, Apelvis may cause some less common adverse reactions, such as headache, hair loss, dry or itchy skin, changes in taste or smell, etc. Although the incidence of these reactions is relatively low, patients still need to pay close attention to their condition and promptly report any discomfort to their doctor. Apelix may also cause some serious adverse reactions, such as severe skin reactions and lung infections. If patients develop unexplained rashes, blisters, skin peeling, or red spots, or unexplained cough, shortness of breath, or difficulty breathing, they should seek medical attention immediately and inform their doctor that they are taking Apelis.

In short, apelvis may cause a series of adverse reactions while treating breast cancer. Patients should pay close attention to their own conditions when using this drug, promptly report any discomfort to their doctor, and follow the doctor's recommendations for treatment and adjustments.